MED
Medifast, Inc.
NYSE · Consumer Cyclical · Personal Products & Services · US
$12.63
+0.72%Aug 27, 2026, 12:30 UTC
Medifast, Inc. launched the Medifast Metabolic Health Institute to advance metabolic health through research and evidence-based education, consolidating its clinical research and scientific expertise under one body.
Source:Aug 3, 2026, 20:05 UTC
Medifast reported its financial results for the second quarter ended June 30, 2026, including revenue of $76.4 million, a net loss of $3.1 million, and cash and investments of $169.8 million.
Jul 17, 2026, 12:30 UTC
Medifast, Inc. launched Trilivy, a science-backed metabolic health system including newly formulated meal replacements with MetaVantage Technology.
Source:Jun 1, 2026, 00:00 UTC
Jason L. Groves resigned as Chief Legal Officer & Corporate Secretary of Medifast Inc, effective May 29, 2026.